Collaboration, License, and Other Agreements - Sonoma Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Apr. 30, 2023	Mar. 31, 2024	Mar. 31, 2023
Sonoma Biotherapeutics, Inc. Collaboration Agreement
Disaggregation of Revenue [Line Items]
Purchase of preferred stock	$ 30.0
Revenue		$ 45.0
Sonoma Biotherapeutics, Inc.
Disaggregation of Revenue [Line Items]
Up-front payment to collaborating party			$ 45.0